Skip to content

Creatine and Perioperative Brain Health

Creatine Intervention in Older Adults to Improve Perioperative Brain Health: a Randomized Controlled Trial (CREATE Trial)

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07310043
Acronym
CREATE
Enrollment
120
Registered
2025-12-30
Start date
2026-09-01
Completion date
2028-08-30
Last updated
2026-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neurocognitive Disorders, Postoperative Delirium

Keywords

Perioperative Brain Health, Creatine, Perioperative Neurocognitive Disorders

Brief summary

The overall goal of this study is to evaluate the feasibility of perioperative oral creatine supplementation and to explore its effects on cognitive function and physiological responses to surgery in older adults. Creatine is commonly used to enhance athletic performance, but it can also have positive effects on the brain. Since surgery can alter thinking, memory, and attention patterns in some patients, we will assess whether creatine affects these changes in older adults undergoing surgery.

Detailed description

Surgical interventions, while often necessary, are associated with substantial postoperative morbidity, particularly among older adults. Perioperative neurocognitive disorders (PND), characterized by changes in memory patterns in the perioperative period, are among the most common surgical complications in aging populations. Beyond their considerable economic burden, estimated to exceed $30 billion annually, PND imposes profound immediate consequences for patients and caregivers and is associated with long-term adverse outcomes, including an increased risk of dementia. Despite their high prevalence and clinical impact, effective, scalable, and easily implementable preventive strategies for PND remain limited. Creatine plays a critical role in supporting the brain's high metabolic demands, and its homeostasis may be disrupted during periods of physiological stress such as anesthesia and surgery. Creatine supplementation has been demonstrated to be neuroprotective in high-stress conditions. However, the potential effects of creatine during perioperative cognitive vulnerability have not been previously investigated. This study will evaluate the feasibility of creatine supplementation in the perioperative period and explore its effects on cognitive function and physiological responses to surgery in older adults.

Interventions

DIETARY_SUPPLEMENTCreatine monohydrate

Participants will receive creatine supplementation before surgery

OTHERPlacebo

Participants in the placebo group will receive an identical placebo before surgery

Sponsors

Massachusetts General Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
60 Years to 85 Years
Healthy volunteers
Yes

Inclusion criteria

* Patients scheduled for elective surgery under general anesthesia

Exclusion criteria

* History of creatine deficiency disorders * Renal or neurodegenerative disorders * History of stroke or significant head trauma, presence of intracranial mass lesions * Inability to give informed consent

Design outcomes

Primary

MeasureTime frameDescription
Preoperative cognitive function assessed with the Montreal Cognitive Assessment (MoCA)Within three weeks before surgeryThe MoCA is a validated tool to assess cognitive function. Scores range from 0-30, with higher scores representing better cognitive function
Postoperative cognitive function assessed with the Montreal Cognitive Assessment (MoCA)Within one month after surgeryThe MoCA is a validated tool to assess cognitive function. Scores range from 0-30, with higher scores representing better cognitive function
Postoperative delirium assessed with the Confusion Assessment Method (CAM)Up to 7 days after surgeryThe CAM is a validated tool to detect postoperative delirium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 11, 2026